Narcolepsy with cataplexy is a debilitating sleep disorder with an estimated prevalence of about 0.05%. Narcolepsy is caused by a selective loss of hypocretin (orexin) producing neurons in the perifornical hypothalamus. Based on the very strong association with the HLA subtype DQB1*0602, it is currently hypothesized narcolepsy is caused by an autoimmune mediated process directed at the hypocretin neurons. So far however, studies focussing on general markers of (auto)immune activation, as well as humoral immunity against the hypocretin system have not yielded consistent results supporting this hypothesis. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
PRACTICE POINTSIn most cases, narcolepsy is a sporadic disorder, althoug first degree relatives have an increased risk.The association with HLA-DQB1*0602 is the strongest of any disorder, but up to 35% of the normal population is positive for this allele.Narcolepsy is caused by a selective loss of hypocretin (orexin) producing neurons in the perifornical hypothalamus. This is reflected in undetectable hypocretin-1 levels in the CSF.An autoimmune mediated destruction of hypocretin neurons remains the most attractive mechanism, but no direct evidence for this theory is available as of yet.
RESEARCH AGENDAAutoantibody screenings in serum and CSF of narcoleptic patients, acquired around disease onset.Studies on T-cell mediated (auto)immunity in relation to the hypocretin system Extend the studies looking for non-HLA factors influencing susceptibility to narcolepsy Additional (post-mortem) histopathological studies in narcolepsy, again particularly around disease onset To search for alternative mechanisms that could result in a hypocretin deficiency.